KEY vs SPRY · P/E 13, rev $7.51B vs rev $89.1M
KeyCorp (KEY) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the KEY and SPRY stock pages for the full models.
Not investment advice.